Article
High expression of TLR3 in triple-negative breast cancer predicts better prognosis —data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays
2022-04-13
Abstract excerpt
INTRODUCTION: We have previously reported that Toll-like receptor 3 (TLR3) acts as a suppressor gene for breast cancer initiation and progression. In this study, we evaluated the role of TLR3 in breast cancer using our original Fudan University Shanghai Cancer Center (FUSCC) datasets and breast cancer tissue microarrays. METHODS: Using FUSCC multiomics datasets on triple- negative breast cancer (TNBC), we compared...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4083ef94-46e9-53b5-8430-73553b633b81
- DOI
- 10.21203/rs.3.rs-1512540/v1
